1. 2022-RA-657-ESGO ENGOT-ov65/KEYNOTE-B96: phase 3, randomized, double-blind study of pembrolizumab versus placebo plus paclitaxel with optional bevacizumab for platinum-resistant recurrent ovarian cancer. (20th October 2022) Authors: Colombo, Nicoletta; Coleman, Robert L; Wu, Xiaohua; Köse, Fatih; Wenham, Robert M; Sebastianelli, Alexandra; Hasegawa, Kosei; Zsiros, Emese; Rouge, Thibault De La Motte; Bidziński, Mariusz; McNeish, Iain; Sehouli, Jalid; Korach, Jacob; Debruyne, Philip R; Kim, Jae-Weon; de Melo, Andréia C; Peng, ... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Optimisation of pharmacy content in clinical cancer research protocols: Experience of the United Kingdom Chemotherapy and Pharmacy Advisory Service. (June 2015) Authors: Debruyne, Philip R; Johnson, Philip J; Pottel, Lies; Daniels, Susanna; Greer, Rachel; Hodgkinson, Elizabeth; Kelly, Stephen; Lycke, Michelle; Samol, Jens; Mason, Julie; Kimber, Donna; Loucaides, Eileen; Parmar, Mahesh KB; Harvey, Sally Journal: Clinical trials Issue: Volume 12:Number 3(2015) Page Start: 257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pain Medication Adherence in Patients with Cancer: A Pragmatic Review. Issue 4 (27th January 2021) Authors: Vanneste, Lorenz; Lefebvre, Tessa; Tack, Laura; Van Eygen, Koen; Cool, Lieselot; Schofield, Patricia A; Boterberg, Tom; De Rijdt, Thomas; Verhaeghe, Anne; Verhelle, Katy; Debruyne, Philip R Journal: Pain medicine Issue: Volume 23:Issue 4(2022) Page Start: 782 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗